ENSPRYNG

Google image searchProduct monograph

Active ingredient

satralizumab, 120 MG/ML

DIN: 02499681

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PRE-FILLED SYRINGE

Schedule: Prescription / Schedule D

Company: HOFFMANN-LA ROCHE LIMITED

Date: 26-AUG-2020

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AC — Interleukin inhibitors (ATC, ATC/DDD)
• L04AC19 — SATRALIZUMAB (ATC/DDD)

External Links for Enspryng

Search on Google

• Enspryng side effects
• Enspryng dosage
• satralizumab side effects
• satralizumab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find enspryng photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.